Cargando…
Evaluation of long-term infusion of dexmedetomidine in critically ill patients: A retrospective analysis
BACKGROUND: Dexmedetomidine is an α2-receptor agonist used for sedation in the intensive care unit (ICU). It is currently FDA indicated for short-term use (i.e., less than 24 h). OBJECTIVES: To compare the safety and efficacy of dexmedetomidine if given long- term (>24 h) to short-term infusion (...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401820/ https://www.ncbi.nlm.nih.gov/pubmed/22837894 http://dx.doi.org/10.4103/2229-5151.97270 |